CC
PHGE icon

Centiva Capital’s BiomX PHGE Stock Holding History

Centiva Capital’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-108
Closed -$200K – 854
2019
Q4 		$200K Buy
+108
New +$186K 0.01% 680

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Centiva Capital's PHGE Position: Q1 2020 in Review

Centiva Capital sold out of BiomX (PHGE) in Q1 2020, closing a stake of 108 shares — an estimated $200K sold.

Centiva Capital first reported a position in PHGE in Q4 2019 and held it in 1 quarter. The position peaked at $200K in Q4 2019. 10 funds tracked by Wall St. Rank hold PHGE as of Q1 2020.

  • Centiva Capital reported no remaining BiomX position as of Q1 2020 after selling out during the quarter.
  • Centiva Capital sold 108 BiomX shares in Q1 2020, an estimated $200K.
  • Centiva Capital first reported a position in BiomX in Q4 2019 and held it in 1 quarter.
  • Centiva Capital's BiomX position peaked at $200K in Q4 2019.
  • 10 funds tracked by Wall St. Rank held BiomX as of Q1 2020.

Based on Centiva Capital's 13F filing for Q1 2020, filed 15 May 2020.